A conflicted clinical trial finds treatment for MS is "safe" but "largely ineffective"
A long-awaited study into Paolo Zamboni’s treatment yields disappointment for most sufferers—yet hope of relief for a few
Paolo Zamboni
An MS trial reported ’definitive’ results before it was done. Why?
Results from a key Canadian study into venoplasty for MS appear to have been prematurely released, leaving questions
The silent treatment: How Canada has failed MS sufferers
Internal documents show why Canada has not kept its promise to accelerate contentious clinical trials for MS
Saskatchewan goes rogue on CCSVI clinical trials
Brad Wall: ’It’s a good day in the province of Saskatchewan’
Hurry up and wait for a CCSVI strategy
MS drugs get fast-tracked all the time. Why can’t a clinical trial get the same treatment?
Liberation therapy: the ’wave of complications’ breaks
Zamboni’s research almost certainly has to have been junk
Liberals push for CCSVI trials in Canada
Private member’s bill would see federal government fund clinical trials of controversial treatment
The Rorschach test of CCSVI research
Experts and journalists are reading whatever they want into a new study examining CCSVI in MS patients
MS liberation: in defence of Saskatchewan
COSH: "There’s no unitary global Science Court where hypotheses can be hauled in for exoneration or hanging"